Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response

被引：15
作者：
Breccia, Massimo [1 ]
Loglisci, Giuseppina [1 ]
Cannella, Laura [1 ]
Finsinger, Paola [1 ]
Mancini, Marco [1 ]
Serrao, Alessandra [1 ]
Santopietro, Michelina [1 ]
Salaroli, Adriano [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy
来源：
LEUKEMIA & LYMPHOMA | 2012年 / 53卷 / 05期
关键词：
AZACITIDINE;
D O I：
10.3109/10428194.2011.643408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：985 / 986
页数：2
相关论文
共 5 条
  • [1] Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
    Cheson, Bruce D.
    Greenberg, Peter L.
    Bennett, John M.
    Lowenberg, Bob
    Wijermans, Pierre W.
    Nimer, Stephen D.
    Pinto, Antonio
    Beran, Miloslav
    de Witte, Theo M.
    Stone, Richard M.
    Mittelman, Moshe
    Sanz, Guillermo F.
    Gore, Steven D.
    Schiffer, Charles A.
    Kantarjian, Hagop
    [J]. BLOOD, 2006, 108 (02) : 419 - 425
  • [2] Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
    Fenaux, Pierre
    Mufti, Ghulam J.
    Hellstrom-Lindberg, Eva
    Santini, Valeria
    Finelli, Carlo
    Giagounidis, Aristoteles
    Schoch, Robert
    Gattermann, Norbert
    Sanz, Guillermo
    List, Alan
    Gore, Steven D.
    Seymour, John F.
    Bennett, John M.
    Byrd, John
    Backstrom, Jay
    Zimmerman, Linda
    McKenzie, David
    Beach, C. L.
    Silverman, Lewis R.
    [J]. LANCET ONCOLOGY, 2009, 10 (03) : 223 - 232
  • [3] Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine
    Itzykson, Raphael
    Thepot, Sylvain
    Quesnel, Bruno
    Dreyfus, Francois
    Beyne-Rauzy, Odile
    Turlure, Pascal
    Vey, Norbert
    Recher, Christian
    Dartigeas, Caroline
    Legros, Laurence
    Delaunay, Jacques
    Salanoubat, Celia
    Visanica, Sorin
    Stamatoullas, Aspasia
    Isnard, Francoise
    Marfaing-Koka, Anne
    de Botton, Stephane
    Chelghoum, Youcef
    Taksin, Anne-Laure
    Plantier, Isabelle
    Ame, Shanti
    Boehrer, Simone
    Gardin, Claude
    Beach, C. L.
    Ades, Lionel
    Fenaux, Pierre
    [J]. BLOOD, 2011, 117 (02) : 403 - 411
  • [4] Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
    Silverman, LR
    Demakos, EP
    Peterson, BL
    Kornblith, AB
    Holland, JC
    Odchimar-Reissig, R
    Stone, RM
    Nelson, D
    Powell, BL
    DeCastro, CM
    Ellerton, J
    Larson, RA
    Schiffer, CA
    Holland, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2429 - 2440
  • [5] The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
    Vardiman, James W.
    Thiele, Juergen
    Arber, Daniel A.
    Brunning, Richard D.
    Borowitz, Michael J.
    Porwit, Anna
    Harris, Nancy Lee
    Le Beau, Michelle M.
    Hellstrom-Lindberg, Eva
    Tefferi, Ayalew
    Bloomfield, Clara D.
    [J]. BLOOD, 2009, 114 (05) : 937 - 951
1